[Protein A tangential flow membrane chromatographic column used for immunoadsorption therapy]

Area of Science:

• Biomedical Engineering
• Immunology
• Materials Science

Context:

• Immunoadsorption therapy is crucial for treating various autoimmune and inflammatory diseases.
• Existing methods face challenges in efficiency and biocompatibility.
• Novel chromatographic column designs are needed to improve therapeutic outcomes.

Purpose:

• To evaluate the performance and biocompatibility of a new tangential flow membrane chromatographic column for immunoadsorption.
• To characterize the relationship between flow rate, backpressure, and fluid viscosity.
• To determine the IgG adsorption capacity of a Protein A-based column using human plasma and blood.

Summary:

• The tangential flow membrane chromatographic column showed minimal damage to blood cells.
• Backpressure increased with fluid viscosity, reaching 0.093 MPa at a blood flow rate of 120 mL/min.
• The Protein A column effectively adsorbed IgG from human plasma and blood, with adsorption capacity influenced by circulation time but not significantly by circulation rate.
• Extracorporeal blood perfusion in dogs confirmed the column's good blood biocompatibility.

Impact:

• This novel column offers a promising advancement in immunoadsorption therapy, potentially improving treatment efficacy and patient safety.
• The findings provide valuable data for optimizing column design and operational parameters for clinical application.
• The demonstrated biocompatibility supports its potential use in extracorporeal blood treatments.